RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALRN
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Aileron Therapeutics Inc stock price on Tuesday moving 11.15% between high and low
(Updated on Jul 23, 2024)

Sell candidate since Jul 17, 2024 Loss -8.03% PDF

The Aileron Therapeutics Inc stock price fell by -0.722% on the last day (Tuesday, 23rd Jul 2024) from $2.77 to $2.75. During the last trading day the stock fluctuated 11.15% from a day low at $2.60 to a day high of $2.89. The price has fallen in 6 of the last 10 days and is down by -12.97% for this period. Volume has increased on the last day by 22 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 38 thousand shares were bought and sold for approximately $103.88 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -33.25% during the next 3 months and, with a 90% probability hold a price between $1.65 and $2.25 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Have specific questions? Chat with our AI Analyst now!

ALRN Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, July 19, 2024, and so far it has risen 0.365%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aileron Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.87 and $3.04. A break-up above any of these levels will issue buy signals. Aileron Therapeutics Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Aileron Therapeutics Inc stock

Aileron Therapeutics Inc finds support from accumulated volume at $2.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.290 between high and low, or 11.15%. For the last week, the stock has had daily average volatility of 9.95%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALRN) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Aileron Therapeutics Inc to open at $2.75, and during the day (based on 14 day Average True Range), to move between $2.49 and $3.01, which gives a possible trading interval of +/-$0.260 (+/-9.44%) up or down from last closing price. If Aileron Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 18.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.74 (0.36%) than the resistance at $2.87 (4.36%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aileron Therapeutics Inc stock A Buy?

Aileron Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.944 Sell Candidate Unchanged

Predicted Opening Price for Aileron Therapeutics Inc of Wednesday, July 24, 2024

Fair opening price July 24, 2024 Current price
$2.75 ( 0.121%) $2.75

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALRN

Fibonacci Support & Resistance Levels

Level Price
R3 3.04 10.42%
R2 2.93 6.40%
R1 2.86 3.91%
Price 2.75
S1 2.64 -4.15%
S2 2.57 -6.64%
S3 2.46 -10.67%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.25 18.18%
R2 3.13 13.82%
R1 2.87 4.36%
Price 2.75
S1 2.74 -0.364%
S2 0 -
S3 0 -

FAQ

What is the symbol for Aileron Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Aileron Therapeutics Inc is ALRN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aileron Therapeutics Inc Stock?
Aileron Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Aileron Therapeutics Inc Stock?
Aileron Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aileron Therapeutics Inc Stock.

What's the current price of Aileron Therapeutics Inc Stock?
As of the end of day on the Jul 23, 2024, the price of an Aileron Therapeutics Inc (ALRN) share was $2.75.

What is the 52-week high and low for Aileron Therapeutics Inc Stock?
The 52-week high for Aileron Therapeutics Inc Stock is $7.42 and the 52-week low is $1.01.

What is the market capitalization of Aileron Therapeutics Inc Stock?
As of the Jul 23, 2024, the market capitalization of Aileron Therapeutics Inc is 59.441M.

When is the next earnings date for Aileron Therapeutics Inc?
The upcoming earnings date for Aileron Therapeutics Inc is Aug 09, 2024.
Click to get the best stock tips daily for free!

About Aileron Therapeutics Inc

Aileron Therapeutics Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... ALRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT